Skip to main content

September 17, 2020, 11:00 am -12:00 pm EDT —

Join us for a free webinar – Registration required

There is now evidence that approaches using medical history–based screening alone fail to identify most individuals with genetic diseases associated with preventable deaths from cancer and heart disease, most notably, hereditary breast and ovarian cancer, Lynch syndrome and familial hypercholesterolemia (CDC Tier 1 genomic applications). Several population-based biobanks and health systems are using a genome-first approach to use results of genetic testing for pathogenic and likely pathogenic variants associated with these conditions in clinical practice.In this webinar, we will be reviewing recent experience and publications on population-based screening for selected adult genetic diseases from two groups, the Geisinger Health System and the Nevada Genome Project. Our speakers will present recent findings and existing evidence for the suitability of DNA -based screening in population and health care-based settings. Our discussant will put the recent findings in context of evidence-based implementation of DNA-based population screening.

Hosted by the Office of Genomics and Precision Public Health, Centers for Disease Control

View the Webinar via Zoom